Boost Pharma Aps Filial
Developing first-in-class stem cell therapy for brittle bone disease.
Yleiskatsaus
- Tuntematon
- Työntekijät
- Tuntematon
- Liikevaihto
- 2021
- Perustettu
Avainpäättäjät
Lilian Walther Jallow
Co-founder & Chief Development Officer (CDO)
John Öhd
Member of Board of Directors
Hans Schambye
Chief Executive Officer (CEO)
Ingelise Saunders
Chairman & CEO (Board)
+9 lisää yhteystietoja Funnelfeedrissä
Kuvaus
BOOST Pharma is a clinical-stage biotechnology company focused on developing treatments for rare diseases. The organization is dedicated to creating a first-in-class cell therapy, known as BT-101, specifically targeting Osteogenesis Imperfecta (OI), or brittle bone disease. This innovative therapy u...